Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: Mucosal melanoma of the upper aerodigestive tract (MM-UADT) occurs in a complex anatomic region. It represents a small number of tumors of the head and neck and a small number of melanoma cases. METHODS: Search strategies initially identified 600, 11 of which were included in this study. RESULTS: All studies involved surgery and radiotherapy. None were randomized, and all were assessed as having a high risk of selection and performance bias. No studies reported quality of life, treatment-related mortality, or morbidity. The results indicate that the addition of radiotherapy to surgery reduces the rate of locoregional recurrence (hazard ratio [HR], 0.60; 95% confidence interval [CI], 0.42-0.87). There was no statistically significant difference in overall survival (HR, 1.16; 95% CI, 0.98-1.37). CONCLUSION: Surgical resection with postoperative radiotherapy remains the optimal treatment strategy for locoregional control. More robust studies and the use of molecular targeted therapies need to be undertaken to improve overall survival. © 2016 Wiley Periodicals, Inc. Head Neck 39: 819-825, 2017.

Original publication

DOI

10.1002/hed.24652

Type

Journal article

Journal

Head Neck

Publication Date

04/2017

Volume

39

Pages

819 - 825

Keywords

melanoma, radiotherapy, sinonasal, surgery, Combined Modality Therapy, Disease-Free Survival, Female, Head and Neck Neoplasms, Humans, Laryngeal Mucosa, Male, Melanoma, Mouth Mucosa, Prognosis, Radiotherapy, Adjuvant, Respiratory Mucosa, Risk Assessment, Surgical Procedures, Operative, Survival Analysis